Quintiles Appoints Lead Medical Expert

Jeffrey A. Spaeder, M.D., has been appointed chief medical and scientific officer at Quintiles. He succeeds Dr. Oren Cohen who now leads Quintiles’ Phase I clinical research business.

Dr. Spaeder will serve as lead medical expert, representing the company on a variety of governance, ethical and scientific issues. He will provide leadership in the ethical conduct of studies and provide guidance on strategic scientific initiatives. Dr. Spaeder will also chair Quintiles’ Drug Safety Committee and serve as vice-chair of Quintiles’ Council on Research Ethics.  

“We are delighted to have a physician and cardiologist of Jeff Spaeder’s stature join Quintiles as our Chief Medical and Scientific Officer,” said Dr. Derek Winstanly, chief customer and governance officer. “He will be the public face and voice of Quintiles, acting as an industry thought leader, and a champion of ethical conduct and behavior.

Dr. Spaeder joins the company having served in several increasingly senior roles within the biopharmaceutical industry. Most recently, he was executive director of global medical affairs for Takeda Pharmaceuticals International, where he developed global medical affairs strategy for the cardio-metabolic and diabetes franchises.